The DNA methylation landscape of advanced prostate cancer

被引:231
作者
Zhao, Shuang G. [1 ,2 ,3 ,4 ]
Chen, William S. [3 ,4 ,6 ]
Li, Haolong [3 ,4 ]
Foye, Adam [4 ,7 ]
Zhang, Meng [3 ,4 ]
Sjostrom, Martin [3 ,4 ]
Aggarwal, Rahul [4 ,7 ]
Playdle, Denise [4 ,7 ]
Liao, Arnold [8 ]
Alumkal, Joshi J. [9 ,10 ]
Das, Rajdeep [3 ,4 ]
Chou, Jonathan [3 ,4 ,7 ]
Hua, Junjie T. [11 ]
Barnard, Travis J. [3 ,4 ]
Bailey, Adina M. [4 ,7 ]
Chow, Eric D. [12 ,13 ]
Perry, Marc D. [3 ,4 ,7 ]
Dang, Ha X. [14 ,15 ,16 ]
Yang, Rendong [17 ]
Moussavi-Baygi, Ruhollah [3 ,4 ]
Zhang, Li [4 ,7 ]
Alshalalfa, Mohammed [3 ]
Chang, S. Laura [3 ]
Houlahan, Kathleen E. [18 ,19 ,20 ]
Shiah, Yu-Jia [18 ]
Beer, Tomasz M. [9 ,21 ]
Thomas, George [9 ,22 ]
Chi, Kim N. [23 ,24 ]
Gleave, Martin [23 ]
Zoubeidi, Amina [23 ]
Reiter, Robert E. [25 ]
Rettig, Matthew B. [25 ,26 ]
Witte, Owen [27 ]
Kim, M. Yvonne [28 ]
Fong, Lawrence [4 ,7 ]
Spratt, Daniel E. [1 ]
Morgan, Todd M. [2 ,5 ,29 ]
Bose, Rohit [4 ,7 ,30 ,31 ]
Huang, Franklin W. [4 ,7 ]
Li, Hui [3 ,4 ]
Chesner, Lisa [3 ,4 ]
Shenoy, Tanushree [4 ,7 ]
Goodarzi, Hani [12 ,30 ]
Asangani, Irfan A. [32 ]
Sandhu, Shahneen [33 ]
Lang, Joshua M. [34 ]
Mahajan, Nupam P. [16 ,35 ]
Lara, Primo N. [36 ,37 ]
Evans, Christopher P. [37 ,38 ]
Febbo, Phillip [8 ]
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA
[3] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[5] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA
[6] Yale Sch Med, New Haven, CT USA
[7] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA
[8] Illumina Inc, San Diego, CA USA
[9] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[10] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[11] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[12] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA
[13] Univ Calif San Francisco, Ctr Adv Technol, San Francisco, CA 94143 USA
[14] Washington Univ, McDonnell Genome Inst, St Louis, MO 63110 USA
[15] Washington Univ, Dept Internal Med, St Louis, MO 63110 USA
[16] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA
[17] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA
[18] Ontario Inst Canc Res, Toronto, ON, Canada
[19] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[20] Univ Calif Los Angeles, Inst Precis Hlth, Dept Human Genet, Los Angeles, CA USA
[21] Oregon Hlth & Sci Univ, Dept Med, Div Hematol Med Oncol, Portland, OR 97201 USA
[22] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA
[23] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada
[24] British Columbia Canc Agcy, Vancouver Ctr, Vancouver, BC, Canada
[25] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med & Urol, Los Angeles, CA 90024 USA
[26] VA Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA
[27] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[28] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[29] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
[30] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[31] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[32] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA
[33] Univ Melbourne, Peter MacCallum Canc Ctr, Victoria, Australia
[34] Univ Wisconsin, Dept Med, Madison, WI USA
[35] Washington Univ, Dept Surg, St Louis, MO 63110 USA
[36] Univ Calif Davis, Div Hematol Oncol, Dept Internal Med, Sacramento, CA 95817 USA
[37] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA
[38] Univ Calif Davis, Dept Urol Surg, Sacramento, CA 95817 USA
[39] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA
[40] Duke Univ, Dept Pathol, Durham, NC 27706 USA
[41] Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands
[42] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
[43] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[44] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[45] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[46] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA
[47] Univ Michigan, Howard Hughes Med Inst, Med Sch, Ann Arbor, MI 48109 USA
[48] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA
[49] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
CPG ISLAND HYPERMETHYLATION; TET2; MUTATIONS; ANDROGEN RECEPTOR; TRANSCRIPTION FACTORS; EPIGENOMIC ANALYSIS; CLONAL EVOLUTION; GENE; GENOME; DNMT3A; HYPOMETHYLATION;
D O I
10.1038/s41588-020-0648-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although DNA methylation is a key regulator of gene expression, the comprehensive methylation landscape of metastatic cancer has never been defined. Through whole-genome bisulfite sequencing paired with deep whole-genome and transcriptome sequencing of 100 castration-resistant prostate metastases, we discovered alterations affecting driver genes that were detectable only with integrated whole-genome approaches. Notably, we observed that 22% of tumors exhibited a novel epigenomic subtype associated with hypermethylation and somatic mutations inTET2,DNMT3B,IDH1andBRAF. We also identified intergenic regions where methylation is associated with RNA expression of the oncogenic driver genesAR,MYCandERG. Finally, we showed that differential methylation during progression preferentially occurs at somatic mutational hotspots and putative regulatory regions. This study is a large integrated study of whole-genome, whole-methylome and whole-transcriptome sequencing in metastatic cancer that provides a comprehensive overview of the important regulatory role of methylation in metastatic castration-resistant prostate cancer. Whole-genome bisulfite sequencing along with whole-genome and transcriptome sequencing of 100 prostate cancer metastases identifies genomic regions that are differentially methylated during disease progression and a novel epigenomic subtype.
引用
收藏
页码:778 / +
页数:14
相关论文
共 107 条
  • [1] The Molecular Taxonomy of Primary Prostate Cancer
    Abeshouse, Adam
    Ahn, Jaeil
    Akbani, Rehan
    Ally, Adrian
    Amin, Samirkumar
    Andry, Christopher D.
    Annala, Matti
    Aprikian, Armen
    Armenia, Joshua
    Arora, Arshi
    Auman, J. Todd
    Balasundaram, Miruna
    Balu, Saianand
    Barbieri, Christopher E.
    Bauer, Thomas
    Benz, Christopher C.
    Bergeron, Alain
    Beroukhim, Rameen
    Berrios, Mario
    Bivol, Adrian
    Bodenheimer, Tom
    Boice, Lori
    Bootwalla, Moiz S.
    dos Reis, Rodolfo Borges
    Boutros, Paul C.
    Bowen, Jay
    Bowlby, Reanne
    Boyd, Jeffrey
    Bradley, Robert K.
    Breggia, Anne
    Brimo, Fadi
    Bristow, Christopher A.
    Brooks, Denise
    Broom, Bradley M.
    Bryce, Alan H.
    Bubley, Glenn
    Burks, Eric
    Butterfield, Yaron S. N.
    Button, Michael
    Canes, David
    Carlotti, Carlos G.
    Carlsen, Rebecca
    Carmel, Michel
    Carroll, Peter R.
    Carter, Scott L.
    Cartun, Richard
    Carver, Brett S.
    Chan, June M.
    Chang, Matthew T.
    Chen, Yu
    [J]. CELL, 2015, 163 (04) : 1011 - 1025
  • [2] Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
    Aggarwal, Rahul
    Huang, Jiaoti
    Alumkal, Joshi J.
    Zhang, Li
    Feng, Felix Y.
    Thomas, George V.
    Weinstein, Alana S.
    Friedl, Verena
    Zhang, Can
    Witte, Owen N.
    Lloyd, Paul
    Gleave, Martin
    Evans, Christopher P.
    Youngren, Jack
    Beer, Tomasz M.
    Rettig, Matthew
    Wong, Christopher K.
    True, Lawrence
    Foye, Adam
    Playdle, Denise
    Ryan, Charles J.
    Lara, Primo
    Chi, Kim N.
    Uzunangelov, Vlado
    Sokolov, Artem
    Newton, Yulia
    Beltran, Himisha
    Demichelis, Francesca
    Rubin, Mark A.
    Stuart, Joshua M.
    Small, Eric J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) : 2492 - +
  • [3] Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
    Aggarwal, Rahul R.
    Quigley, David A.
    Huang, Jiaoti
    Zhang, Li
    Beer, Tomasz M.
    Rettig, Matthew B.
    Reiter, Rob E.
    Gleave, Martin E.
    Thomas, George, V
    Foye, Adam
    Playdle, Denise
    Lloyd, Paul
    Chi, Kim N.
    Evans, Christopher P.
    Lara, Primo N.
    Feng, Felix Y.
    Alumkal, Joshi J.
    Small, Eric J.
    [J]. MOLECULAR CANCER RESEARCH, 2019, 17 (06) : 1235 - 1240
  • [4] DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases
    Aryee, Martin J.
    Liu, Wennuan
    Engelmann, Julia C.
    Nuhn, Philipp
    Gurel, Meltem
    Haffner, Michael C.
    Esopi, David
    Irizarry, Rafael A.
    Getzenberg, Robert H.
    Nelson, William G.
    Luo, Jun
    Xu, Jianfeng
    Isaacs, William B.
    Bova, G. Steven
    Yegnasubramanian, Srinivasan
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (169)
  • [5] Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]
  • [6] TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
    Bejar, Rafael
    Lord, Allegra
    Stevenson, Kristen
    Bar-Natan, Michal
    Perez-Ladaga, Albert
    Zaneveld, Jacques
    Wang, Hui
    Caughey, Bennett
    Stojanov, Petar
    Getz, Gad
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Chen, Rui
    Stone, Richard M.
    Neuberg, Donna
    Steensma, David P.
    Ebert, Benjamin L.
    [J]. BLOOD, 2014, 124 (17) : 2705 - 2712
  • [7] Enhancer methylation dynamics contribute to cancer plasticity and patient mortality
    Bell, Rachel E.
    Golan, Tamar
    Sheinboim, Danna
    Malcov, Hagar
    Amar, David
    Salamon, Avi
    Liron, Tamar
    Gelfman, Sahar
    Gabet, Yankel
    Shamir, Ron
    Levy, Carmit
    [J]. GENOME RESEARCH, 2016, 26 (05) : 601 - 611
  • [8] The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
    Beltran, Himisha
    Hruszkewycz, Andrew
    Scher, Howard I.
    Hildesheim, Jeffrey
    Isaacs, Jennifer
    Yu, Evan Y.
    Kelly, Kathleen
    Lin, Daniel
    Dicker, Adam
    Arnold, Julia
    Hecht, Toby
    Wicha, Max
    Sears, Rosalie
    Rowley, David
    White, Richard
    Gulley, James L.
    Lee, John
    Meco, Maria Diaz
    Small, Eric J.
    Shen, Michael
    Knudsen, Karen
    Goodrich, David W.
    Lotan, Tamara
    Zoubeidi, Amina
    Sawyers, Charles L.
    Rudin, Charles M.
    Loda, Massimo
    Thompson, Timothy
    Rubin, Mark A.
    Tawab-Amiri, Abdul
    Dahut, William
    Nelson, Peter S.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (23) : 6916 - 6924
  • [9] Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    Beltran, Himisha
    Prandi, Davide
    Mosquera, Juan Miguel
    Benelli, Matteo
    Puca, Loredana
    Cyrta, Joanna
    Marotz, Clarisse
    Giannopoulou, Eugenia
    Chakravarthi, Balabhadrapatruni V. S. K.
    Varambally, Sooryanarayana
    Tomlins, Scott A.
    Nanus, David M.
    Tagawa, Scott T.
    Van Allen, Eliezer M.
    Elemento, Olivier
    Sboner, Andrea
    Garraway, Levi A.
    Rubin, Mark A.
    Demichelis, Francesca
    [J]. NATURE MEDICINE, 2016, 22 (03) : 298 - 305
  • [10] Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains
    Berman, Benjamin P.
    Weisenberger, Daniel J.
    Aman, Joseph F.
    Hinoue, Toshinori
    Ramjan, Zachary
    Liu, Yaping
    Noushmehr, Houtan
    Lange, Christopher P. E.
    van Dijk, Cornelis M.
    Tollenaar, Rob A. E. M.
    Van den Berg, David
    Laird, Peter W.
    [J]. NATURE GENETICS, 2012, 44 (01) : 40 - U62